Company Overview and News

 
Indian banks to sell Vijay Mallya#39;s cars #39;shortly#39; in UK

13h moneycontrol
A UK High Enforcement Officer is set to sell a fleet of Vijay Mallya's cars in the UK as part of efforts to recover loan repayment dues owed by the beleaguered liquor baron to a consortium of 13 Indian banks, the banks' legal representative confirmed on October 19.
IOB 500116 500469 UDBKL IDBI UBLS FDBAY 532505 FEDA 532179 532388 PNJZY 532461 CRPKY UBLA FEDS PNB CORPBANK UCOBANK FEDERALBNK SBAZ

 
Vinay Mittal, wanted in 7 bank frauds of worth Rs 40 crore, extradited from Indonesia

2018-10-16 freepressjournal.in
New Delhi: Absconding industrialist Vinay Mittal, wanted in seven bank fraud cases worth Rs 40 crore, has been extradited to India from Indonesia, officials said Tuesday. His name had figured in the list of prominent fugitive economic offenders of the Government which contained names of Vijay Mallya, Nitin Sandesara, Nirav Modi, Mehul Choksi, Jatin Mehta among others.
532179 PNJZY 532461 CRPKY PNB CORPBANK

1
Vinay Mittal extradited from Indonesia

2018-10-16 thehindubusinessline - 1
Absconding industrialist Vinay Mittal, wanted in seven bank fraud cases worth Rs 40 crore, has been extradited to India from Indonesia, CBI officials said Tuesday.
532179 PNJZY 532461 CRPKY PNB CORPBANK

 
Corporation Bank - Updates

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532179 CRPKY CORPBANK

 
Corporation Bank robbery case: Two of six accused arrested, raids conducted to nab others

2018-10-14 financialexpress
The police have arrested two persons in connection with the Corporation Bank robbery case in which a cashier was killed. The incident happened on Friday in which six men were involved in carrying out the act. According to a PTI report, all the accused have been identified and the officials are carrying out raids to nab them.
532179 CRPKY CORPBANK

 
Shocking robbery in Delhi – Cashier of Corporation Bank shot dead, Rs 2 lakh looted

2018-10-13 financialexpress
In a shocking case of robbery, a cashier of Corporation Bank was shot dead in New Delhi’s Dwarka today. The incident took place at a branch of Corporation Bank in Chhawla area in southwest Delhi. Three persons were injured after four unidentified assailants opened fire at them and looted the cash worth Rs 2 Lakh, according to Police.
532179 CRPKY CORPBANK

 
RBI#39;s corrective action on 12 banks limited losses, saved taxpayer money: Viral Acharya

2018-10-12 moneycontrol
Prompt Corrective Action (PCA) imposed on 12 banks has limited their losses and saved taxpayer money, according to the central bank’s Deputy Governor Viral Acharya.
IOB 500116 UDBKL IDBI ALBK UBLS 532505 532179 532388 532121 CRPKY UBLA 532480 CORPBANK UCOBANK DENABANK

 
Corporation Bank - Allotment of Securities

2018-10-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532179 CRPKY CORPBANK

 
CBI books Hyd-based firm in Rs 1,700-cr bank fraud case

2018-09-28 freepressjournal.in
New Delhi : The CBI has booked Hyderabad-based telecom equipment manufacturer VMC Systems and its promoters in an alleged bank fraud case of Rs 1,700 crore on the complaint of Punjab National Bank, which is reeling under the $2 billion fraud committed by jewellers Nirav Modi and Mehul Choksi.
532179 PNJZY 532461 CRPKY 532418 PNB CORPBANK ANDHRABANK SBAZ

 
Punjab National Bank board approves proposal to raise Rs 5,431 crore fund from government

2018-09-27 moneycontrol
The board of Punjab National Bank (PNB) approved proposal to seek Rs 5,431 crore capital support from the government.
532179 PNJZY 532461 CRPKY 532418 PNB CORPBANK ANDHRABANK

 
Govt in talks with state banks for capital infusion

2018-09-27 freepressjournal.in
The government will infuse Rs 65,000 crore in the banks during the current fiscal as was announced earlier
532179 PNJZY 532461 CRPKY 532418 PNB CORPBANK ANDHRABANK

 
PNB shares rise 3% after bank announces Rs 5,431-crore fund raising plan

2018-09-26 financialexpress
Shares of public-sector lender Punjab National Bank (PNB) rose over 3% on Wednesday after the bank said its board will consider an infusion of Rs 5,431 crore by the government. Following the announcement, PNB shares jumped 3.35% to an intra-day high of Rs 69.30 per share on the BSE. However, the stock trimmed some gains to close trade at Rs 67.15, up 0.15%.
532179 PNJZY 532461 CRPKY 532418 PNB CORPBANK ANDHRABANK

 
Govt may infuse Rs 2,350cr in Central Bank to boost capital base

2018-09-20 moneycontrol
In a bid to help the Central Bank of India meet capital requirements as per the Reserve Bank of India (RBI)'s guidelines, the government is planning to infuse Rs 2,350 crore in the bank, according to a report by Business Standard.
IOB ALBK 532418 532401 VIJAYABANK 532179 532388 PNJZY 532121 532461 CRPKY 532480 PNB CORPBANK DENABANK ANDHRABANK

 
Dena Bank, Bajaj Corp, UCO Bank, MMTC, Jubilant Food top gainers among BSE Group A stocks

2018-09-18 moneycontrol
The Indian benchmark indices continues to trade in the red and have extended the earlier loses this Tuesday afternoon with the Nifty50 down 73 points and is trading at 11,304 while the Sensex is trading lower by 214 points at 37,370.
500429 GALLANTT 532726 532505 HINDUNILVR 533155 JUBLFOOD 532179 532121 CRPKY UNIPHOS JBLWY 500696 CORPBANK UCOBANK DENABANK

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...